
WhiteLab Genomics provides an AI-driven platform that speeds discovery and design of genomic therapies, reducing time and experimental workload. It combines graph knowledge technology, machine learning, and advanced computational biology to perform in-silico design and optimization of vectors, payloads, genotoxicity assessment, and experimental protocols. The platform supports modalities including AAV, lentiviral, and nanoparticle delivery and is used by biopharmaceutical companies and research institutions. WhiteLab's tools integrate into genomic R&D workflows to de-risk early development and accelerate candidate selection for downstream preclinical testing.

WhiteLab Genomics provides an AI-driven platform that speeds discovery and design of genomic therapies, reducing time and experimental workload. It combines graph knowledge technology, machine learning, and advanced computational biology to perform in-silico design and optimization of vectors, payloads, genotoxicity assessment, and experimental protocols. The platform supports modalities including AAV, lentiviral, and nanoparticle delivery and is used by biopharmaceutical companies and research institutions. WhiteLab's tools integrate into genomic R&D workflows to de-risk early development and accelerate candidate selection for downstream preclinical testing.
What they do: AI-driven platform (ALFRED AI) for design and optimization of genomic medicines (AAV, lentiviral, non-viral vectors, payloads, bioproduction)
Founded: 2019
Headquarters / presence: Paris, Boston, Montréal
Funding: $10M seed (Sep 12, 2022); pre-seed tied to Y Combinator (Mar 2022)
Investors / partners: Debiopharm Group, Omnes Capital, Y Combinator
| Company |
|---|
Accelerating and de-risking genomic medicine R&D (gene and cell therapy development).
2019
Biotechnology
Pre-seed round associated with Y Combinator
10000000
Seed round announced Sep 12, 2022
“Debiopharm Group and Omnes Capital are lead investors; Y Combinator participated in earlier round”
Talent Acquisition & Operations:
Lead end-to-end recruitment for scientific and technical roles
Build and maintain strong talent pipelines
Manage external recruitment partners
Employer Branding & Partnerships:
Contribute to employer branding and referral programs
Develop university and academic partnerships
Represent the company at recruitment events and conferences
Ensure a consistent, positive and engaging employee experience
Onboarding, Data & continous improvment:
Coordinate onboarding and integration across locations
Track and analyze recruitment KPIs
Continuously improve processes, tools, and practices
Contribute to broader People & Culture initiativesWe’re Eager to Meet You If You…
Have proven international Talent Acquisition experience (≥2 years), ideally in DeepTech and/or Life Sciences
Have hands-on end-to-end recruitment experience (sourcing to offer, negotiation, references)
Are comfortable managing recruitment agencies and/or an RPO model
Excel at sourcing technical and specialized profiles beyond LinkedIn (events, academia, niche communities)
Are skilled in proactive sourcing and modern recruiting tools (automation, AI, campaigns)
Can manage multiple parallel recruitments across Europe and North America in fast-growing environments
Act as a trusted partner to hiring managers, providing structure, coaching, and data-driven recommendations
Are business-oriented, autonomous, well-organized, and execution-focused
Have strong communication and stakeholder management skills in an international contextFirst video call with our People & Culture Asosciate
Deeper dive – chat with the Head of People & Culture
PI assessment
Meet us in person – case study + team meetings
Final checks – references
Let’s make it official – offer